PASTEUR Act of 2026

[Congressional Bills 119th Congress] [From the U.S. Government Publishing Office] [H.R. 7352 Introduced in House (IH)] <DOC> 119th CONGRESS 2d Session H. R. 7352 To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES February 4, 2026 Mr. Carter of Georgia (for himself, Mr. Peters, Mr. Langworthy, Mr. Levin, and Mr. Carey) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Budget, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend the Public Health Service Act to establish a program to develop innovative antimicrobial drugs targeting the most challenging pathogens and most threatening infections, and for other purposes. Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Pioneering Antimicrobial Subscriptions To End Upsurging Resistance Act of 2026'' or the ``PASTEUR Act of 2026''. SEC. 2. PURPOSE. The purpose of this Act is to ensure the availability of antimicrobials to-- (1) stimulate a new age of research, development, and market access to lifesaving medicines; (2) ensure the appropriate use of lifesaving medicines; (3) maintain the highest medical care standards for American patients; (4) promote national health system preparedness; and (5) defend the United States and its military. SEC. 3. DEVELOPING ANTIMICROBIAL INNOVATIONS. Title III of the Public Health Service Act (42 U.S.C. 241 et seq.) is amended by adding at the en